Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral zinc sulfate for reduction of bilirubin in term jaundiced neonates during phototherapy
IRCT201312067697N3Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of zinc in neonatal hyperbilirubinemia, sponsored by Lorestan University of Medical Sciences. Primary endpoint: Change in serum bilirubin level during phototherapy. Started Jan 2014; status: completed.
02
Drugs
zinc
03
Conditions
neonatal hyperbilirubinemia
Beyond the preview
Go deeper on IRCT201312067697N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201312067697N3.